Outlook on the Microcarrier Global Market to 2027 - Key Players Include Thermo Fisher Scientific, Merck, Eppendorf and Danaher Among Others - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Microcarrier Market, Size, Share, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.
This report provides a detailed analysis of the Microcarriers Industry. The global microcarrier market is estimated to reach US$ 2.24 Billion by 2027, from S$ 1.48 Billion in 2021.
Globally, a microcarrier is a non-toxic finely particulate material used to grow cells in a suspension or a support matrix, which facilitates the growth of adherent cells in a bioreactor. Recently, microcarrier-based cell culture has attracted significant attention from scientists and technologists worldwide.
Besides, microcarrier technology has advantages for producing significant numbers of functional cells and maintaining their unique phenotypes as a powerful source of cell therapy and tissue engineering. With improved microcarrier materials, especially purely natural-material microcarriers, tissue engineering has a bright future.
Global Microcarrier Is Expected to Expand at a CAGR of 7.1% During 2021-2027:
Over the years, factors such as the increasing incidence of diseases demanding cell therapy and boosting R&D funding by research institutes and biopharmaceutical companies have played a critical role in market expansion. Further, the rising demand for monoclonal antibodies for the targeted treatment of cancer and other chronic disorders is expected to create significant opportunities for market growth during the forecast period.
In addition, the increasing prevalence of cancer cases is playing an essential role in developing the microcarrier market. Also, the growing demand for cell-based vaccines is fuelling the market's growth over the forecast period.
COVID-19 Is Anticipated to Have a Noteworthy Impact On the Microcarrier Market:
In our report, we have closely observed the impact of COVID-19 on the global microcarrier market. After WHO officially announced COVID-19 as a pandemic, several renowned pharmaceutical companies, research institutes, and start-ups geared their R&D efforts to devise drugs and vaccines for infectious diseases. Further, due to advanced R&D activities and funding, the need for cell culture products, including microcarrier products, is anticipated to grow over the subsequent years.
This will provide a significant stimulus to the global market for microcarriers. As per this research report, Global Microcarrier Market was US$ 1.48 Billion in 2021.
North America is Envisioned to Dominate the Market Over the Forecast Period:
As per our analysis, the North American region is believed to have the largest share in the microcarrier market. The rising gene and cell therapy analysis in the area and the associations sponsoring this research are the major factors supporting its growth.
For instance, the American Society of Gene and Cell Therapy are liable for funding the research; this society is compelling the biopharmaceutical and biotech companies to improve their R&D. Besides, the United States is also glimpsing high and rapid augmentation in the biologics and biosimilar Industry. It is one of the influential factors propelling the microcarrier market in the North American region.
Product - Global Microcarriers Market have been covered from 2 viewpoints:
Application - Global Microcarriers Market have been covered from 4 viewpoints:
- Biopharmaceutical Production
- Cell and Gene Therapy
- Tissue Engineering and Regenerative Medicine
- Other Applications
End Use - Global Microcarriers Market have been covered from 3 viewpoints:
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations & Contract Manufacturing Organizations
- Academic and Research Institutes
Region - Global Microcarriers Market have been covered from 4 viewpoints:
- North America
- Recent Development
- Thermo Fisher Scientific
- Merck KGaA
- Eppendorf AG
- Danaher Corporation
- Sartorius AG
- Lonza Group
- Getinge AB Series B
- GE Healthcare
- Corning Inc
- Becton, Dickinson and Company
For more information about this report visit https://www.researchandmarkets.com/r/vizmb2
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900